Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Irradiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04966195
What this trial is testing

Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombosisStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Looking for participantsNCT05027711
What this trial is testing

Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases

Who this might be right for
Hepatic Metastasis
University Hospital Heidelberg 90
Early research (Phase 1)Ended earlyNCT01862718
What this trial is testing

Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms

Who this might be right for
Liver NeoplasmsHepatic CancerLiver Cancer
National Institutes of Health Clinical Center (CC) 5
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Testing effectiveness (Phase 2)Looking for participantsNCT07122089
What this trial is testing

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis 80
Testing effectiveness (Phase 2)Looking for participantsNCT07012798
What this trial is testing

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableEnded earlyNCT02336763
What this trial is testing

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more
Jonsson Comprehensive Cancer Center 2
Not applicableStudy completedNCT03108248
What this trial is testing

ISP-TACE Versus TACE for HCC With PVTT

Who this might be right for
HCCPortal Vein Tumor Thrombosis
Zhongda Hospital 126
Not applicableStudy completedNCT03436550
What this trial is testing

Assessment of Portal Hypertension With Multiparametric MRI

Who this might be right for
Portal HypertensionClinically Significant Portal Hypertension
Icahn School of Medicine at Mount Sinai 69
Testing effectiveness (Phase 2)Looking for participantsNCT06823375
What this trial is testing

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Who this might be right for
HCC
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Not applicableUnknownNCT05339581
What this trial is testing

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant; ComplicationsHepatocellular Carcinoma+2 more
RenJi Hospital 78
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Testing effectiveness (Phase 2)UnknownNCT02913417
What this trial is testing

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Who this might be right for
Uveal MelanomaHepatic Metastases
David Minor, MD 26
Testing effectiveness (Phase 2)UnknownNCT02290977
What this trial is testing

Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Samsung Medical Center 40
Large-scale testing (Phase 3)UnknownNCT04167293
What this trial is testing

Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06867432
What this trial is testing

Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 20
Not applicableNot Yet RecruitingNCT07320755
What this trial is testing

Analysis of Computed Tomography Derived Maps for Determining Changes of the Liver Volume After Exposure to Radiotherapy

Who this might be right for
Intra-abdominal MalignanciesLiver as Organ at RiskRadiation-related Liver Changes
Assiut University 70
Not applicableUnknownNCT04682847
What this trial is testing

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Who this might be right for
Liver NeoplasmsHepatic CirrhosisHepatic Carcinoma+6 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 40
Not applicableLooking for participantsNCT07070076
What this trial is testing

A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Li Qiang 286
Next Page